Penumbra enrolls first patient in trial of Lightning Flash thrombectomy system

Penumbra has enrolled the first patient in STORM-PE, a randomized controlled trial evaluating anticoagulation alone vs anticoagulation plus Lightning Flash for the treatment of pulmonary embolism – PE -. In partnership with PERT Consortium, a multi-disciplinary group dedicated to improving the care of patients with PE, the STORM-PE trial aims to advance the understanding of the role of computer assisted vacuum thrombectomy – CAVT – in the management of acute PE, with a goal of improving the outcomes for patients with this life-threatening condition. STORM-PE will enroll up to 100 participants at up to 20 sites. Penumbra’s Lightning Flash can be used to remove emboli and thrombi from vessels of the peripheral arterial and venous systems and can be used for the treatment of PE.